Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$129,707,515
+$37,075,323 QoQ
Shares Held
1,805,003
+130.3% QoQ
Ownership
0.437%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#44
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Man Group plc holds $452,779,482 across 30 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (28.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
1,805,003 | $129,707,515 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
601,019 | $101,295,742 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
134,890 | $73,087,447 | |
| 4 | VTRS |
Viatris Inc
|
3,523,052 | $55,946,065 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,530,206 | $15,898,840 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
732,867 | $7,328,670 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
156,422 | $7,275,186 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
1,451,781 | $7,157,279 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $129,707,515 | 1,805,003 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $92,632,192 | 783,624 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $98,993,413 | 786,786 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $113,763,214 | 777,496 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $71,562,803 | 458,883 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $78,154,249 | 474,669 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $69,859,658 | 428,771 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $90,726,655 | 464,360 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $78,244,648 | 451,342 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $125,185,109 | 739,821 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,428,780 | 103,505 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $21,164,143 | 121,647 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $25,058,276 | 145,510 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $49,320,331 | 296,325 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $34,419,025 | 234,862 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $77,965,839 | 525,766 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $140,898,919 | 819,704 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $167,823,976 | 889,888 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $55,018,514 | 225,458 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $108,205,092 | 557,356 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $164,063,888 | 880,360 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $86,327,070 | 548,178 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,222,953 | 79,897 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $16,237,514 | 98,189 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,591,216 | 99,177 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,479,282 | 123,029 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||